Affectis Pharmaceuticals
Manufacturing · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Otto-hahn-straße 15, Dortmund, Nordrhein...Phone Number
+49 23197427000Website
www.affectis.comRevenue
$11.1 MillionIndustry
About Affectis Pharmaceuticals
Is Affectis Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Affectis Pharmaceuticals launches new products
Check out if Affectis Pharmaceuticals is spiking on competitors!
Check if Affectis Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Affectis Pharmaceuticals
Earning: See what the market has to say on Affectis Pharmaceuticals recently announced quarterly report
Affectis Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Affectis Pharmaceuticals has new funding data
Click to see if Affectis Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Affectis Pharmaceuticals
Find 3 more new buyers
Company Profile Activity
Activity Insights
Affectis Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Affectis Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Affectis Pharmaceuticals.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Affectis Pharmaceuticals
Founded in 2004 and headquartered in Germany, Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.... Read More